Contribution of age to clinical trial enrollment and tolerance with ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Contribution of age to clinical trial enrollment and tolerance with ovarian cancer

Published:2017-04 Issue:1 Volume:145 Page:32-36
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Gillen Jessica,Gunderson Camille,Greenwade Molly,Rowland Michelle,Ruskin Rachel,Ding Kai,Crim Aleia,Walter Adam,White Emily,Moore Kathleen

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference23 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J. Clin.,2016

2. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration;Talarico;J. Clin. Oncol.,2004

3. http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER web site,2008

4. Future of cancer incidence in the United States: burdens upon an aging, changing nation;Smith;J. Clin. Oncol.,2009

5. Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group;Vercelli;Crit. Rev. Oncol. Hematol.,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of race/ethnicity and age in clinical trial knowledge among patients with gynecologic malignancy;Gynecologic Oncology;2024-11

2. Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial;European Journal of Cancer;2023-03

3. Perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in elderly women with epithelial ovarian cancer: analysis of a prospective registry;International Journal of Gynecologic Cancer;2021-05-18

4. A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma;Clinical Epigenetics;2018-11-16

5. Neoadjuvant chemotherapy in high-risk ovarian cancer patients: Role of age;Tumori Journal;2018-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3